Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the prostate cancer lifestyle trial

Nutrition and Cancer

Volumn 58, Issue 1, 2007, Pages 35-42

  Dewell, Antonella ^a   Weidner, Gerdi ^a   Sumner, Michael D ^a   Barnard, R James ^b   Marlin, Ruth O ^a   Daubenmier, Jennifer J ^c   Chi, Christine ^a   Carroll, Peter R ^c   Ornish, Dean ^a  

^a Preventive Medicine Research Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE DERIVATIVE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOYBEAN PROTEIN;

ADULT; ARTICLE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SOYBEAN;

ANIMALIA;

EID: 34447542902     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701308034     Document Type: Article

References (43)

1. Djavan B, Waldert M, Seitz C, and Marberger M: Insulin-like growth factors and prostate cancer. World J Urol 19, 225-233, 2001.
2. Yu H and Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92, 1472-1489, 2000.
3. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, et al.: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346-1353, 2004.
4. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, et al.: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94, 1099-1106, 2002.
5. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, and Aronson WJ: Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 13, 929-935, 2002.
6. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, and Golding LA: A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 56, 201-206, 2003.
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, et al.: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279, 563-566, 1998.
8. Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, et al.: Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 10, 421-427, 2001.
9. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, et al.: Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 12, 84-89, 2003.
10. Holmes MD, Pollak MN, Willett WC, and Hankinson SE: Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11, 852-861, 2002.
11. Larsson SC, Wolk K, Brismar K, and Wolk A: Association of diet with serum insulin-like growth factor I in middle-aged and elderly men. Am J Clin Nutr 81, 1163-1167, 2005.
12. Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, et al.: The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 11, 1441-1448, 2002.
13. Thissen JP, Ketelslegers JM, and Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 15, 80-101, 1994.
14. Smith WJ, Underwood LE, and Clemmons DR: Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 80, 443-449, 1995.
15. Clemmons DR, Seek MM, and Underwood LE: Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting. Metabolism 34, 391-395, 1985.
16. Phillips LS, Harp JB, Goldstein S, Klein J, and Pao CI: Regulation and action of insulin-like growth factors at the cellular level. Proc Nutr Soc 49, 451-458, 1990.
17. Sim HG and Cheng CW: Changing demography of prostate cancer in Asia. Eur J Cancer 41, 834-845, 2005.
18. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, et al.: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129, 1628-1635, 1999.
19. Zhou JR, Yu L, Zhong Y, Nassr RL, Franke AA, et al.: Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate 53, 143-153, 2002.
20. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, et al.: Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132, 552S-558S, 2002.
21. Jarred RA, Keikha M, Dowling C, McPherson SJ, Clare AM, et al.: Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 11, 1689-1696, 2002.
22. Probst-Hensch NM, Wang H, Goh VH, Seow A, Lee HP, et al.: Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 12, 739-746, 2003.
23. Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, et al.: Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr 132, 2605-2608, 2002.
24. Adams KF, Newton KM, Chen C, Emerson SS, Potter JD, et al.: Soy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial. J Nutr 133, 1316-1319, 2003.
25. Gann PH, Kazer R, Chatterton R, Gapstur S, Thedford K, et al.: Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer 116, 297-303, 2005.
26. Spentzos D, Mantzoros C, Regan MM, Morrissey ME, Duggan S, et al.: Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients. Clin Cancer Res 9, 3282-3287, 2003.
27. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, et al.: Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174, 1065-1069; discussion 1069-1070, 2005.
28. Dunn-Emke SR, Weidner G, Pettengill EB, Marlin RO, Chi C, et al.: Nutrient adequacy of a very low-fat vegan diet. J Am Diet Assoc 105, 1442-1446, 2005.
29. Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, et al.: Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology 67, 125-130, 2006.
30. Ornish DM, Lee KL, Fair WR, Pettengill EB, and Carroll PR: Dietary trial in prostate cancer: Early experience and implications for clinical trial design. Urology 57, 200-201, 2001.
31. Wright JD, Wang CY, Kennedy-Stephenson J, and Ervin RB: Dietary intake often key nutrients for public health, United States: 1999-2000. Adv Data 1-4, 2003.
32. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, et al.: Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2, and -3 in women in the Netherlands. Cancer Causes Control 15, 787-796, 2004.
33. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, et al.: Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 33, 139-145, 1999.
34. Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, et al.: Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal 13, 166-172, 1999.
35. Food and Nutrition Board Institute of Medicine: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academy Press, 2002.
36. Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets. J Am Diet Assoc 103, 748-765, 2003.
37. Cohen P: Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence. J Natl Cancer Inst 90, 876-879, 1998.
38. Harman SM, Metter EJ, Blackman MR, Landis PK, and Carter HB: Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85, 4258-4265, 2000.
39. Yu H, Nicar MR, Shi R, Berkel HJ, Nam R, et al.: Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence. Urology 57, 471-475, 2001.
40. Janssen JA, Wildhagen MF, Ito K, Blijenberg BG, Van Schaik RH, et al.: Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval. J Clin Endocrinol Metab 89, 4391-4396, 2004.
41. Hsing AW, Chua S, Jr., Gao YT, Gentzschein E, Chang L, et al.: Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93, 783-789, 2001.
42. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, et al.: Insulin regulatesthe serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66, 266-272, 1988.
43. Allen NE, Appleby PN, Davey GK, and Key TJ: Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer 83, 95-97, 2000.